@article{9d0f29877972427fbbea2ca6805442c9,
title = "Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial",
abstract = "Sugammadex (Org 25969), a novel, selective relaxant binding agent, was specifically designed to rapidly reverse rocuronium-induced neuromuscular blockade. The efficacy and safety of sugammadex for the reversal of profound, high-dose rocuronium-induced neuromuscular blockade was evaluated.",
keywords = "Androstanols, Anesthesia, Intravenous, Anesthetics, Intravenous, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Toxicity, Female, Humans, Male, Middle Aged, Neuromuscular Blockade, Neuromuscular Depolarizing Agents, Propofol, gamma-Cyclodextrins",
author = "P{\"u}hringer, {Friedrich K} and Christopher Rex and Sielenk{\"a}mper, {Andreas W} and Casper Claudius and Larsen, {Per Bo} and Prins, {Martine E} and Matthias Eikermann and Khuenl-Brady, {Karin S}",
year = "2008",
month = aug,
day = "1",
doi = "10.1097/ALN.0b013e31817f5bc7",
language = "English",
volume = "109",
pages = "188--97",
journal = "Anesthesiology News",
issn = "0747-4679",
publisher = "McMahon Group",
number = "2",
}